PURPOSE: The aim of the study was to evaluate the effect of phosphorus-32 colloid ([(32)P]) intracavitary irradiation on the treatment of patients with cystic craniopharyngiomas. METHODS: Twenty patients with predominantly cystic craniopharyngiomas were admitted from 1981 to 2006. Eleven patients had [(32)P] intracavitary irradiation by stereotactic injection or Ommaya cyst instillation as the primary treatment, and the remaining nine had the same internal irradiation as an adjuvant treatment after tumor resection. A calculated irradiation dose of 400 approximately 500 Gy per once was delivered to the cyst wall. CONCLUSION: The patients were followed up ranging from 36 to 336 months; no operative morbidity or mortality was found from [(32)P] intracavitary irradiation. Fourteen patients (70%) had tumor progression and required further two to four times intracavitary irradiation. All 20 cases achieved tumor shrinkage or stabilization with effective outcome 3-6 months after the last [(32)P] therapy. For patients with cystic craniopharyngioma, [(32)P] administration by stereotactic injection or Ommaya cyst instillation is a safe and helpful option, which could improve the life quality, prolong the life span, and enhance the survival rate of cystic craniopharyngioma patients.
PURPOSE: The aim of the study was to evaluate the effect of phosphorus-32 colloid ([(32)P]) intracavitary irradiation on the treatment of patients with cystic craniopharyngiomas. METHODS: Twenty patients with predominantly cystic craniopharyngiomas were admitted from 1981 to 2006. Eleven patients had [(32)P] intracavitary irradiation by stereotactic injection or Ommaya cyst instillation as the primary treatment, and the remaining nine had the same internal irradiation as an adjuvant treatment after tumor resection. A calculated irradiation dose of 400 approximately 500 Gy per once was delivered to the cyst wall. CONCLUSION: The patients were followed up ranging from 36 to 336 months; no operative morbidity or mortality was found from [(32)P] intracavitary irradiation. Fourteen patients (70%) had tumor progression and required further two to four times intracavitary irradiation. All 20 cases achieved tumor shrinkage or stabilization with effective outcome 3-6 months after the last [(32)P] therapy. For patients with cystic craniopharyngioma, [(32)P] administration by stereotactic injection or Ommaya cyst instillation is a safe and helpful option, which could improve the life quality, prolong the life span, and enhance the survival rate of cystic craniopharyngiomapatients.
Authors: P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther Journal: J Natl Cancer Inst Date: 2000-02-02 Impact factor: 13.506
Authors: E O Backlund; B Axelsson; C G Bergstrand; A L Eriksson; G Norén; E Ribbesjö; T Rähn; P O Schnell; L Tallstedt; M Sääf Journal: Acta Neurochir (Wien) Date: 1989 Impact factor: 2.216
Authors: O M Dekkers; N R Biermasz; J W A Smit; L E Groot; F Roelfsema; J A Romijn; A M Pereira Journal: Eur J Endocrinol Date: 2006-03 Impact factor: 6.664
Authors: V Taasan; B Shapiro; J A Taren; W H Beierwaltes; P McKeever; R L Wahl; J E Carey; N Petry; S Mallette Journal: J Nucl Med Date: 1985-11 Impact factor: 10.057
Authors: Ana M Denis-Bacelar; Marina Romanchikova; Sarah Chittenden; Frank H Saran; Henry Mandeville; Yong Du; Glenn D Flux Journal: Eur J Nucl Med Mol Imaging Date: 2013-06-06 Impact factor: 9.236
Authors: M Mazzuia Guimarães; D Dante Cardeal; M Jacobsen Teixeira; J Erasmo Dal Col Lucio; F Hada Sanders; R Kei Kuromoto; H Matushita Journal: Childs Nerv Syst Date: 2021-10-07 Impact factor: 1.475
Authors: Mohammad Maarouf; Faycal El Majdoub; Manuel Fuetsch; Mauritius Hoevels; Ralph Lehrke; Frank Berthold; Jürgen Voges; Volker Sturm Journal: Strahlenther Onkol Date: 2015-11-05 Impact factor: 3.621